Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Portage Biotech Inc Ord (PRTG)

Portage Biotech Inc Ord (PRTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Portage Biotech Inc Ord CLARENCE THOMAS BUILDING P.O. BOX 4649 ROAD TOWN TORTOLA D8 VG1110

www.portagebiotech.com Employees: 4 P: 302-219-5556

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Key Statistics

Overview:

Market Capitalization, $K 7,142
Enterprise Value, $K 5,472
Shares Outstanding, K 1,049
Float, K 608
% Float 57.93%
Short Volume Ratio 0.41
% of Insider Shareholders 42.07%
% of Institutional Shareholders 13.36%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -6,770 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,360 K
EBIT, $ -11,720 K
EBITDA, $ -11,680 K

Growth:

1-Year Return 84.05%
3-Year Return -95.88%
5-Year Return -96.60%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.26 on 11/26/24
Next Earnings Date 09/09/25
Earnings Per Share ttm -7.65
EPS Growth vs. Prev Qtr 20.25%
EPS Growth vs. Prev Year 78.28%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 08/15/24

PRTG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.79
Interest Coverage -0.60
60-Month Beta 0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar